MedTrace Logo

Evaluation of NICOM (Bioreactance) for the Non-invasive Determination of Cardiac Output

NCT02331329 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41

Last updated 2015-01-06

No results posted yet for this study

Summary

Cardiac output (CO) is an important parameter in the diagnosis and therapy of cardiac diseases. The current standard methods for the determination of CO, however, are either invasive (e.g. right heart catheterization) or technically expendable and expensive (magnetic resonance tomography, MRT). Therefore, the aim of the study at hand was to evaluate NICOM (bioreactance) as a new method for determinion of CO and to compare this new technique to MRT.

Conditions

  • Cardiac Disease

Interventions

DEVICE

NICOM cardiac output measurement

DEVICE

Cardiac MRT cardiac output measurement

Sponsors & Collaborators

  • Universitätsmedizin Mannheim

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-06-30
Completion
2014-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02331329 on ClinicalTrials.gov